Decreased susceptibility to antimicrobials among Shigella flexneri isolates in Manipal, South India - A 5 year hospital based study

Ballal Mamatha, Chakraborty Rituparna

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Shigellosis is endemic in many developing countries and an important cause of bloody diarrhea worldwide. Our study was undertaken as a continuation of our earlier study during 2001-2006. The aim of this study was to monitor changes in Shigella serogroups and resistance patterns to antimicrobials among Shigella isolates. Two thousand one hundred fecal samples were obtained from patients with diarrhea during June 2006 - June 2011. Isolates were identified by standard microbiological techniques as Shigella spp and the disk diffusion method was used to determine antimicrobial susceptibility following CLSI guidelines. Of the 2,100 fecal samples, 77 (3.7%) contained Shigella spp, of which 73 (94.8%) were S.flexneri, 3 (3.9%) were S. sonnei and 1 (1.3%) was S. dysentriae type 1. S. boydii was not identified. One hundred percent resistance was noted against nalidixic acid. There were high levels of resistance to other antimicrobials: ampicillin (100%), Co-trimoxazole (89.6%), tetracycline (84.4%), ciprofloxacin (87%) and norfloxacin (83.1%). Most of the isolates were susceptible to ceftriaxone except for 2 isolates of S. flexneri. Antibiotic treatment of shigellosis is needed to prevent mortality. Increasing fluoroquinolone resistance leaves us dependent on third generation cephalosporins for treating shigellosis. Emerging resistance to these cephalosporins was seen in our study.

Original languageEnglish
Pages (from-to)1447-1451
Number of pages5
JournalSoutheast Asian Journal of Tropical Medicine and Public Health
Volume43
Issue number6
Publication statusPublished - 01-11-2012

Fingerprint

Shigella flexneri
Shigella
Bacillary Dysentery
India
Diarrhea
Cephalosporin Resistance
Microbiological Techniques
Norfloxacin
Nalidixic Acid
Ceftriaxone
Fluoroquinolones
Sulfamethoxazole Drug Combination Trimethoprim
Cephalosporins
Ampicillin
Ciprofloxacin
Tetracycline
Developing Countries
Guidelines
Anti-Bacterial Agents
Mortality

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

@article{7fa9dc49097947d98271db272de3051e,
title = "Decreased susceptibility to antimicrobials among Shigella flexneri isolates in Manipal, South India - A 5 year hospital based study",
abstract = "Shigellosis is endemic in many developing countries and an important cause of bloody diarrhea worldwide. Our study was undertaken as a continuation of our earlier study during 2001-2006. The aim of this study was to monitor changes in Shigella serogroups and resistance patterns to antimicrobials among Shigella isolates. Two thousand one hundred fecal samples were obtained from patients with diarrhea during June 2006 - June 2011. Isolates were identified by standard microbiological techniques as Shigella spp and the disk diffusion method was used to determine antimicrobial susceptibility following CLSI guidelines. Of the 2,100 fecal samples, 77 (3.7{\%}) contained Shigella spp, of which 73 (94.8{\%}) were S.flexneri, 3 (3.9{\%}) were S. sonnei and 1 (1.3{\%}) was S. dysentriae type 1. S. boydii was not identified. One hundred percent resistance was noted against nalidixic acid. There were high levels of resistance to other antimicrobials: ampicillin (100{\%}), Co-trimoxazole (89.6{\%}), tetracycline (84.4{\%}), ciprofloxacin (87{\%}) and norfloxacin (83.1{\%}). Most of the isolates were susceptible to ceftriaxone except for 2 isolates of S. flexneri. Antibiotic treatment of shigellosis is needed to prevent mortality. Increasing fluoroquinolone resistance leaves us dependent on third generation cephalosporins for treating shigellosis. Emerging resistance to these cephalosporins was seen in our study.",
author = "Ballal Mamatha and Chakraborty Rituparna",
year = "2012",
month = "11",
day = "1",
language = "English",
volume = "43",
pages = "1447--1451",
journal = "Southeast Asian Journal of Tropical Medicine and Public Health",
issn = "0125-1562",
publisher = "Southeast Asian Ministers of Education Organisation",
number = "6",

}

TY - JOUR

T1 - Decreased susceptibility to antimicrobials among Shigella flexneri isolates in Manipal, South India - A 5 year hospital based study

AU - Mamatha, Ballal

AU - Rituparna, Chakraborty

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Shigellosis is endemic in many developing countries and an important cause of bloody diarrhea worldwide. Our study was undertaken as a continuation of our earlier study during 2001-2006. The aim of this study was to monitor changes in Shigella serogroups and resistance patterns to antimicrobials among Shigella isolates. Two thousand one hundred fecal samples were obtained from patients with diarrhea during June 2006 - June 2011. Isolates were identified by standard microbiological techniques as Shigella spp and the disk diffusion method was used to determine antimicrobial susceptibility following CLSI guidelines. Of the 2,100 fecal samples, 77 (3.7%) contained Shigella spp, of which 73 (94.8%) were S.flexneri, 3 (3.9%) were S. sonnei and 1 (1.3%) was S. dysentriae type 1. S. boydii was not identified. One hundred percent resistance was noted against nalidixic acid. There were high levels of resistance to other antimicrobials: ampicillin (100%), Co-trimoxazole (89.6%), tetracycline (84.4%), ciprofloxacin (87%) and norfloxacin (83.1%). Most of the isolates were susceptible to ceftriaxone except for 2 isolates of S. flexneri. Antibiotic treatment of shigellosis is needed to prevent mortality. Increasing fluoroquinolone resistance leaves us dependent on third generation cephalosporins for treating shigellosis. Emerging resistance to these cephalosporins was seen in our study.

AB - Shigellosis is endemic in many developing countries and an important cause of bloody diarrhea worldwide. Our study was undertaken as a continuation of our earlier study during 2001-2006. The aim of this study was to monitor changes in Shigella serogroups and resistance patterns to antimicrobials among Shigella isolates. Two thousand one hundred fecal samples were obtained from patients with diarrhea during June 2006 - June 2011. Isolates were identified by standard microbiological techniques as Shigella spp and the disk diffusion method was used to determine antimicrobial susceptibility following CLSI guidelines. Of the 2,100 fecal samples, 77 (3.7%) contained Shigella spp, of which 73 (94.8%) were S.flexneri, 3 (3.9%) were S. sonnei and 1 (1.3%) was S. dysentriae type 1. S. boydii was not identified. One hundred percent resistance was noted against nalidixic acid. There were high levels of resistance to other antimicrobials: ampicillin (100%), Co-trimoxazole (89.6%), tetracycline (84.4%), ciprofloxacin (87%) and norfloxacin (83.1%). Most of the isolates were susceptible to ceftriaxone except for 2 isolates of S. flexneri. Antibiotic treatment of shigellosis is needed to prevent mortality. Increasing fluoroquinolone resistance leaves us dependent on third generation cephalosporins for treating shigellosis. Emerging resistance to these cephalosporins was seen in our study.

UR - http://www.scopus.com/inward/record.url?scp=84873019361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873019361&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 1447

EP - 1451

JO - Southeast Asian Journal of Tropical Medicine and Public Health

JF - Southeast Asian Journal of Tropical Medicine and Public Health

SN - 0125-1562

IS - 6

ER -